FDA OKs New Tool to Aid Dx of Degenerative Brain Diseases

NM-101, from Terran Biosciences, is a cloud-based software platform to analyze neuromelanin-sensitive MRI scans, which could aid in the diagnosis of neurodegenerative diseases.

Related Keywords

New York ,United States ,Guillermo Horga ,David Sulzer ,Sam Clark ,Columbia University Vagelos College Of Physicians ,Drug Administration ,Terran Biosciences ,Biosciences Founder ,Columbia University Vagelos College ,Parkinson Amp 039s Disease ,Arkinsons Parkinson Disease Pd ,Scan ,Brain ,Neurodegenerative Disease ,Neuroimaging ,Biomarker ,Iological Marker ,Ulti Biomarker Disease Activity ,Bda ,Multibiomarker Disease Activity ,Hospitals ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Mental Illness ,Mental Disorder ,Sychiatric Disorder ,